Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookAssessment of the Pharmaceutical Situation in Kenya - A Baseline Survey (HAI, WHO; 2003; 78 pages)
View the documentLIST OF ABBREVIATIONS
View the documentACKNOWLEDGEMENTS
View the document1. EXECUTIVE SUMMARY
Open this folder and view contents2. INTRODUCTION
Open this folder and view contents3. SURVEY DESIGN AND METHODOLOGY
close this folder4. RESULTS AND ANALYSIS
close this folder4.1 LEVEL I CORE INDICATORS
View the document4.1.1 National Medicine Policy
View the document4.1.2 Legislation/regulation
View the document4.1.3 Quality control of pharmaceuticals
View the document4.1.4 Essential medicines list
View the document4.1.5 Medicines supply system
View the document4.1.6 Medicines financing
View the document4.1.7 Access to essential medicines
View the document4.1.8 Production
View the document4.1.9 Rational use
Open this folder and view contents4.2 LEVEL II CORE INDICATORS
View the document5. CONCLUSION
View the document6. POSITIVE ASPECTS AND AREAS FOR IMPROVEMENT IDENTIFIED
View the document7. SUMMARY OF RECOMMENDATIONS
Open this folder and view contentsAPPENDICES
 

4.1.9 Rational use

• Standard treatment guidelines (STG) produced by the MOH was last reviewed in 2002.

• There is no National Medicines Formulary manual.

• There are no continuing education programs, medicines information centre or public education campaign concerning rational medicines use although there is a government department with a specific mandate to promote rational use of medicines and co-ordinate medicines use policies.

• All referral hospitals and a few general hospitals have drugs and therapeutics committees.


Interpretation:

The results from level I indicators suggest that, although the basic structures that are considered necessary for implementing a national medicine policy exists the performance of the structures is not optimal.

Recommendations:

• The KNDP needs to be revised so as to include the regulation of traditional medicines.

• Improve the capacity of the Pharmacy and Poisons Board to effectively carry out its role.

• There is a need to allocate more funds to the health sector especially to cater for medicines.**


• There is need to develop a pricing policy on medicines.

Strategies need to be developed so as to promote rational use of medicines.

• A functional National Pharmacy and Therapeutics Committee needs to be established, supported (financially and technically) and sustained.

• A functional National Medicines Management Information System/Logistics Management Information System needs to be established, supported (financially and technically) and sustained

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French